These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3364767)

  • 1. Variability of the activated coagulation time.
    Gravlee GP; Case LD; Angert KC; Rogers AT; Miller GS
    Anesth Analg; 1988 May; 67(5):469-72. PubMed ID: 3364767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
    Watanabe T; Abe T; Iyomasa Y
    Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of blood loss and heparin rebound following cardiopulmonary bypass.
    Pifarre R; Sullivan HJ; Montoya A; Bakhos M; Grieco J; Foy BK; Blakeman B
    Semin Thromb Hemost; 1989 Apr; 15(2):173-7. PubMed ID: 2787532
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring heparin for anticoagulation during cardiopulmonary bypass].
    Li LH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Dec; 10(4):251-5. PubMed ID: 7160291
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
    Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
    Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin management by activated coagulation time during cardiopulmonary bypass].
    Shikano K; Shinpo H; Nasu M; Morimoto T; Suzuki T; Yada I; Kusagawa M
    Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.